Kai Eberhardt
CEO & Co-Founder @ Oviva
Zürich, Switzerland
Kai Eberhardt is a seed investor at Oviva in Zürich focused on Health Care and Medical. Digital health entrepreneur, mission and purpose-driven to make a positive difference. Past as McKinsey junior partner and PhD in Physics from ETH Zürich & Harvard.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Kai Eberhardt invests in
Stages Kai Eberhardt invests in
Countries Kai Eberhardt invests in
Round sizes
Round size
- Seed
- $6M–$6.3M
Investment Focus
Industry
- Health Care 2 (67%)
- Medical 1 (33%)
- Internet 1 (33%)
- Software 1 (33%)
- Personal Health 1 (33%)
Stage
- Seed 2 (67%)
- Pre-Seed 1 (33%)
Country
- Switzerland 2 (67%)
- Germany 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ahead Health
|
Ahead Health is redefining preventive healthcare by making personalized health insights clear, actionable, and accessible anytime, anywhere | $6M / Seed / Jan 13, 2026 | |
Mirantus Health
|
Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients. | $6.3M / Seed / Nov 20, 2025 | |
Everyman Health
|
Everyman Health ist Spezialist für Männergesundheit und bietet wissenschaftlich fundierte Lösungen für Männer aller Altersgruppen. In Zusammenarbeit mit unseren Partnern, bieten wir dir ein umfassendes Portfolio von digitalen, medikamentösen und nicht-medikamentösen Therapien für unterschiedliche Männerprobleme.Über unsere Plattform wirst du inwenigen Minuten mit einem Schweizer Facharzt verbunden und erhältst eine persönliche Diagnose und gegebenenfalls ein Rezept.Auf Wunsch wird deine persönliche Behandlung von einer lizenzierten Schweizer Apotheke diskret verpackt und dir kostenlos bis vor die Haustür geliefert. | $1.7M / Pre-Seed / Nov 30, 2023 |
Co-Investors
About Oviva
Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform.They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allowspatients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.Oviva was founded in 2013 and is based in Altendorf (Switzerland) with offices in Zurich (Switzerland), London (United Kingdom), and Berlin (Germany).
Oviva Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Nydegger
CPO
|
|||
|
Kai Eberhardt
CEO & Co-Founder
|
|||
|
Kimberley Baxter
HR Manager
|
|||
Manuel Baumann
CTO & Co-Founder
|
|||
Mark Jenkins
UK Managing & Medical Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Kai Eberhardt invest in?
Kai Eberhardt invests primarily in Health Care, Medical and Internet startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Kai Eberhardt's check size?
Kai Eberhardt typically joins rounds of $6M–$6.3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kai Eberhardt participates in.
When did Kai Eberhardt last invest?
The most recent investment recorded for Kai Eberhardt closed in Jan 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
